Herrmann May N, Cao A, Schmid A, Link F, Arias-Del-Angel J, Meiser E
Elife. 2025; 13.
PMID: 39991929
PMC: 11850003.
DOI: 10.7554/eLife.97437.
Damasceno J, Briggs E, Krasilnikova M, Marques C, Lapsley C, McCulloch R
Nat Commun. 2025; 16(1):1470.
PMID: 39922816
PMC: 11807225.
DOI: 10.1038/s41467-025-56785-y.
Howell J, Omwenga S, Jimenez M, Hammarton T
PLoS One. 2024; 19(10):e0311367.
PMID: 39361666
PMC: 11449296.
DOI: 10.1371/journal.pone.0311367.
Rana N, Grover P, Singh H
Curr Top Med Chem. 2024; 24(6):541-579.
PMID: 38288806
DOI: 10.2174/0115680266290152240110074034.
Joshi H, Tuli H, Ranjan A, Chauhan A, Haque S, Ramniwas S
Molecules. 2023; 28(22).
PMID: 38005250
PMC: 10673037.
DOI: 10.3390/molecules28227530.
Profilin is involved in G1 to S phase progression and mitotic spindle orientation during Leishmania donovani cell division cycle.
Ambaru B, Gangadharan G, Subramanya H, Gupta C
PLoS One. 2022; 17(3):e0265692.
PMID: 35316283
PMC: 8939790.
DOI: 10.1371/journal.pone.0265692.
Identification of Potential Kinase Inhibitors within the PI3K/AKT Pathway of Species.
Ochoa R, Ortega-Pajares A, Castello F, Serral F, Fernandez do Porto D, Villa-Pulgarin J
Biomolecules. 2021; 11(7).
PMID: 34356660
PMC: 8301987.
DOI: 10.3390/biom11071037.
A Molecular Modeling Approach to Identify Potential Antileishmanial Compounds Against the Cell Division Cycle (cdc)-2-Related Kinase 12 (CRK12) Receptor of .
Broni E, Kwofie S, Asiedu S, Miller 3rd W, Wilson M
Biomolecules. 2021; 11(3).
PMID: 33803906
PMC: 8003136.
DOI: 10.3390/biom11030458.
Protein Kinases: Important Regulators of the Parasite Life Cycle and Molecular Targets for Treating Leishmaniasis.
Efstathiou A, Smirlis D
Microorganisms. 2021; 9(4).
PMID: 33801655
PMC: 8066228.
DOI: 10.3390/microorganisms9040691.
Systematic functional analysis of Leishmania protein kinases identifies regulators of differentiation or survival.
Baker N, Catta-Preta C, Neish R, Sadlova J, Powell B, Alves-Ferreira E
Nat Commun. 2021; 12(1):1244.
PMID: 33623024
PMC: 7902614.
DOI: 10.1038/s41467-021-21360-8.
The SENP Protease Is Required for SUMO Processing but Not for Viability.
Bea A, Krober-Boncardo C, Sandhu M, Brinker C, Clos J
Genes (Basel). 2020; 11(10).
PMID: 33066659
PMC: 7602377.
DOI: 10.3390/genes11101198.
Antikinetoplastid Activity of Indolocarbazoles from .
Cartuche L, Sifaoui I, Lopez-Arencibia A, Bethencourt-Estrella C, San Nicolas-Hernandez D, Lorenzo-Morales J
Biomolecules. 2020; 10(4).
PMID: 32344693
PMC: 7226613.
DOI: 10.3390/biom10040657.
Towards discovery of new leishmanicidal scaffolds able to inhibit GSK-3.
Martinez de Iturrate P, Sebastian-Perez V, Nacher-Vazquez M, Tremper C, Smirlis D, Martin J
J Enzyme Inhib Med Chem. 2019; 35(1):199-210.
PMID: 31752556
PMC: 6882465.
DOI: 10.1080/14756366.2019.1693704.
Unveiling the Kinomes of and Empowers the Discovery of New Kinase Targets and Antileishmanial Compounds.
Borba J, Silva A, Ramos P, Grazzia N, Miguel D, Muratov E
Comput Struct Biotechnol J. 2019; 17:352-361.
PMID: 30949306
PMC: 6429582.
DOI: 10.1016/j.csbj.2019.02.005.
Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis.
Wyllie S, Thomas M, Patterson S, Crouch S, De Rycker M, Lowe R
Nature. 2018; 560(7717):192-197.
PMID: 30046105
PMC: 6402543.
DOI: 10.1038/s41586-018-0356-z.
Genetically Validated Drug Targets in Leishmania: Current Knowledge and Future Prospects.
Jones N, Catta-Preta C, Lima A, Mottram J
ACS Infect Dis. 2018; 4(4):467-477.
PMID: 29384366
PMC: 5902788.
DOI: 10.1021/acsinfecdis.7b00244.
Conditional gene deletion with DiCre demonstrates an essential role for CRK3 in Leishmania mexicana cell cycle regulation.
Duncan S, Myburgh E, Philipon C, Brown E, Meissner M, Brewer J
Mol Microbiol. 2016; 100(6):931-44.
PMID: 26991545
PMC: 4913733.
DOI: 10.1111/mmi.13375.
Genetic Manipulation of Leishmania donovani to Explore the Involvement of Argininosuccinate Synthase in Oxidative Stress Management.
Sardar A, Jardim A, Ghosh A, Mandal A, Das S, Saini S
PLoS Negl Trop Dis. 2016; 10(3):e0004308.
PMID: 26939071
PMC: 4777552.
DOI: 10.1371/journal.pntd.0004308.
Kinases as druggable targets in trypanosomatid protozoan parasites.
Merritt C, Silva L, Tanner A, Stuart K, Pollastri M
Chem Rev. 2015; 114(22):11280-304.
PMID: 26443079
PMC: 4254031.
DOI: 10.1021/cr500197d.
An inhibitor-driven study for enhancing the selectivity of indirubin derivatives towards leishmanial Glycogen Synthase Kinase-3 over leishmanial cdc2-related protein kinase 3.
Efstathiou A, Gaboriaud-Kolar N, Smirlis D, Myrianthopoulos V, Vougogiannopoulou K, Alexandratos A
Parasit Vectors. 2014; 7:234.
PMID: 24886176
PMC: 4039064.
DOI: 10.1186/1756-3305-7-234.